On-Demand Event

15 min. Highlights from
The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients?

An accredited symposium at CCC 2019

Original air date:
Saturday, October 26, 2019

Running time: 14:26 minutes

Featuring

Shamir R. Mehta, MD, MSc, FRCPC, FACC, FESC
Robert Welsh, MD, FRCPC, FACC, FAHA, FESC

Watch Dr. Shamir R. Mehta and Dr. Robert Welsh discuss the highlights of the symposium entitled The Great Debate: Aspirin, DAPT or dual pathway inhibition for secondary prevention in stable ASCVD patients? presented at the Canadian Cardiovascular Congress in October 2019.

Language: English

Therapeutic area: Cardiology/Vascular Disease